Literature DB >> 33999864

Utilization of Low-Dose Naltrexone for Burning Mouth Syndrome: A Case Report.

Daniel L Neuman1, Andrea L Chadwick.   

Abstract

Burning mouth syndrome is a chronic pain condition characterized by a burning sensation of the oropharynx. The pathophysiology of burning mouth syndrome includes peripheral and central sensitization. Treatment is generally aimed at symptom reduction. We describe a woman in her seventh decade with burning mouth syndrome that had been refractory to treatment for nearly a decade. Low-dose naltrexone has been reported to provide analgesia in central sensitization states and was successful in reducing pain severity in our patient. We conclude that low-dose naltrexone may be a therapeutic option for patients with burning mouth syndrome who are refractory to conventional therapies.
Copyright © 2021 International Anesthesia Research Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33999864      PMCID: PMC8311810          DOI: 10.1213/XAA.0000000000001475

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  15 in total

Review 1.  The burning mouth syndrome remains an enigma.

Authors:  Joanna M Zakrzewska
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

2.  Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study.

Authors:  J Bergdahl; G Anneroth; H Perris
Journal:  J Oral Pathol Med       Date:  1995-05       Impact factor: 4.253

Review 3.  Cellular and molecular mechanisms of pain.

Authors:  Allan I Basbaum; Diana M Bautista; Grégory Scherrer; David Julius
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

4.  Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

Authors:  Jarred Younger; Sean Mackey
Journal:  Pain Med       Date:  2009-04-22       Impact factor: 3.750

Review 5.  Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis.

Authors:  Federica Galli; Giovanni Lodi; Andrea Sardella; Elena Vegni
Journal:  Cephalalgia       Date:  2016-07-11       Impact factor: 6.292

Review 6.  Burning mouth syndrome: a review on diagnosis and treatment.

Authors:  E C Coculescu; A Radu; B I Coculescu
Journal:  J Med Life       Date:  2014 Oct-Dec

7.  Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia.

Authors:  Luke Parkitny; Jarred Younger
Journal:  Biomedicines       Date:  2017-04-18

Review 8.  Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions.

Authors:  Olivia C Eller-Smith; Andrea L Nicol; Julie A Christianson
Journal:  Front Cell Neurosci       Date:  2018-02-13       Impact factor: 5.505

Review 9.  Burning mouth syndrome: A review on its diagnostic and therapeutic approach.

Authors:  R Aravindhan; Santhanam Vidyalakshmi; Muniapillai Siva Kumar; C Satheesh; A Murali Balasubramanium; V Srinivas Prasad
Journal:  J Pharm Bioallied Sci       Date:  2014-07

Review 10.  Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.

Authors:  Karlo Toljan; Bruce Vrooman
Journal:  Med Sci (Basel)       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.